+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brachytherapy Market - Global Forecast 2026-2032- Product Image
Brachytherapy Market - Global Forecast 2026-2032- Product Image
Sale

Brachytherapy Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083897
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brachytherapy Market is projected to reach USD 1.14 Billion in 2026. It is expected to continue growing at a CAGR of 6.90%, reaching USD 1.71 Billion by 2032.

Brachytherapy: Executive Summary and Clinical Context

Brachytherapy is a form of internal radiation therapy in which sealed radioactive sources are placed within or near a tumor to deliver a localized dose. It is used across several cancer pathways, including gynecological, prostate, breast, skin, and selected head-and-neck cancers. Clinical value depends on appropriate patient selection, accurate imaging, applicator placement, treatment planning, radiation safety, and coordinated multidisciplinary care.

How Image Guidance and Precision Care Are Transforming Brachytherapy

The field is shifting toward image-guided, adaptive, and highly personalized treatment workflows. Magnetic resonance imaging, computed tomography, ultrasound, and hybrid imaging can improve target visualization and support more accurate applicator positioning and dose optimization. Remote afterloading, three-dimensional planning, improved immobilization, and workflow digitization are also helping institutions strengthen reproducibility, safety, and treatment efficiency. Adoption remains influenced by equipment access, specialist availability, training requirements, reimbursement, and the complexity of integrating brachytherapy into broader oncology services.

Artificial Intelligence Is Supporting Planning, Segmentation, and Quality Assurance

Artificial intelligence is increasingly being evaluated for automated image segmentation, organ-at-risk delineation, treatment-plan assistance, adaptive decision support, and quality assurance. These applications may reduce repetitive tasks and improve consistency, but clinical use requires robust validation across imaging protocols, disease sites, and patient populations. Human oversight remains essential because anatomical variation, applicator geometry, prior treatment, and treatment intent can materially affect decisions. Data governance, explainability, cybersecurity, and regulatory compliance are therefore central to responsible implementation.

Regional Insights: Uneven Access and Different Adoption Priorities

North America generally emphasizes advanced image guidance, specialized oncology centers, clinical protocols, and integrated radiation-services infrastructure. Europe combines established brachytherapy expertise with strong interest in adaptive planning, quality standards, and cross-border clinical research. Asia-Pacific includes highly capable centers alongside substantial variation in equipment access, workforce capacity, and referral pathways. Latin America is shaped by public-private differences, affordability constraints, and the need to expand trained teams and maintenance support. The Middle East is investing in tertiary cancer services while addressing workforce development and concentration of expertise. Africa faces the greatest infrastructure and access challenges, making dependable equipment, training partnerships, and sustainable service models particularly important.

Group Insights: Policy, Trade, and Health-System Structures Shape Capability

ASEAN markets reflect varied health-system maturity and benefit from regional training, referral coordination, and shared technical standards. BRICS members span major oncology systems and developing service environments, creating different priorities around local manufacturing, workforce development, and equitable access. The European Union benefits from common regulatory and clinical frameworks while retaining national differences in reimbursement and service organization. G7 countries tend to emphasize technology-enabled precision care, evidence generation, and mature quality systems. GCC members are strengthening specialist cancer infrastructure and may benefit from coordinated workforce and procurement strategies. NATO members encompass diverse health systems, but interoperability, resilience, emergency preparedness, and secure digital infrastructure are relevant cross-national priorities.

Country Insights: Distinct National Priorities Across Major Care Systems

Australia combines specialist cancer services with geographic-access challenges that make referral networks and telehealth-supported coordination important. Brazil must address regional disparities and differences between public and private provision. Canada’s geography reinforces the importance of centralized expertise, coordinated referrals, and equitable access. China is expanding sophisticated oncology capacity while continuing to standardize services across regions. France, Germany, Italy, and Spain have established radiation-oncology capabilities but differ in organization, reimbursement, workforce distribution, and technology adoption. India is balancing rapid expansion of cancer services with affordability, training, and rural access. Japan and South Korea have advanced hospital systems and strong technical capabilities, with continued focus on precision, workflow integration, and aging-population needs. Mexico is working to broaden access and strengthen specialized oncology capacity. Russia’s priorities include maintaining technical capability, workforce continuity, and access across a large geography. The United Kingdom emphasizes evidence-based pathways, centralized guidance, and service productivity. The United States combines extensive specialist capacity with attention to outcomes, safety, reimbursement, and access disparities.

Actions for Leaders: Build Evidence, Capability, and Reliable Patient Pathways

Industry leaders should prioritize clinically validated solutions that integrate imaging, planning, delivery, and quality assurance rather than adding isolated technology. Health systems can strengthen outcomes by investing in multidisciplinary training, standardized protocols, structured peer review, equipment maintenance, and referral pathways that identify suitable patients early. Technology developers should design interoperable, explainable, and secure tools with rigorous prospective evaluation and clear human-oversight requirements. Organizations entering underserved regions should consider training partnerships, service agreements, mobile or hub-and-spoke models where appropriate, and total-cost-of-ownership planning. All stakeholders should track clinically meaningful outcomes, toxicity, treatment completion, patient experience, and equity of access.

Research Methodology: Evidence-Based Interpretation of the Brachytherapy Landscape

This executive summary uses a structured review framework focused on the clinical role of brachytherapy, treatment delivery, imaging, planning, artificial intelligence, workforce, infrastructure, regulation, and access. Regional, group, and country perspectives are synthesized from established patterns in oncology-system organization and technology adoption rather than from market estimates or forecasts. Conclusions should be interpreted alongside peer-reviewed clinical evidence, professional-society guidance, national cancer strategies, regulatory materials, reimbursement policies, and institution-level outcome data. Because capabilities vary substantially within countries and groups, local validation is necessary before making investment or implementation decisions.

Conclusion: Precision, Access, and Workforce Capacity Will Define Progress

Brachytherapy remains a specialized treatment modality whose effectiveness depends on accurate localization, disciplined execution, and coordinated cancer care. Image guidance, adaptive planning, automation, and artificial intelligence can improve precision and operational consistency when deployed with strong clinical governance. Progress across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific will depend not only on technology, but also on trained professionals, dependable infrastructure, equitable referral systems, and evidence-based standards. Leaders that align innovation with safety, measurable outcomes, and patient access will be best positioned to strengthen the role of brachytherapy in modern oncology.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Brachytherapy Market, by Treatment Type
7.1. Introduction
7.2. Interstitial
7.3. Intracavitary
7.4. Surface
8. Brachytherapy Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Cancer Institutes
8.4. Hospitals
9. Brachytherapy Market, by Application
9.1. Introduction
9.2. Breast
9.2.1. Hybrid
9.2.2. MammoSite
9.2.3. SAVIScout
9.3. Gynecological
9.4. Head And Neck
9.4.1. Laryngeal
9.4.2. Oral
9.4.3. Oropharyngeal
9.5. Prostate
10. Brachytherapy Market, by Equipment Type
10.1. Introduction
10.2. Afterloaders
10.3. Applicators
10.4. Imaging Systems Integration
10.5. Treatment Planning Systems
11. Brachytherapy Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Brachytherapy Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Brachytherapy Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Accuray Incorporated
15.2. BEBIG Medical GmbH
15.3. Becton, Dickinson and Company
15.4. Best Medical International, Inc.
15.5. BWX Technologies. Inc.
15.6. CivaTech Oncology Inc.
15.7. CIVCO Medical Solutions
15.8. CQ Medical
15.9. Eckert & Ziegler Radiopharma GmbH
15.10. Elekta AB
15.11. GammaTile
15.12. Healvita Group GmbH
15.13. Hologic, Inc.
15.14. IsoAid, LLC
15.15. Mick Radio-Nuclear Instruments, Inc.
15.16. Mirion Technologies, Inc.
15.17. Perspective Therapeutics
15.18. Theragenics Corporation
15.19. Varian Medical Systems, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Brachytherapy Market, Years Considered for the Study
FIGURE 2. Global Brachytherapy Market, Research Design
FIGURE 3. Global Brachytherapy Market, Research Framework
FIGURE 4. Global Brachytherapy Market, Data Triangulation
FIGURE 5. Global Brachytherapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Brachytherapy Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 7. Global Brachytherapy Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Brachytherapy Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Brachytherapy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Brachytherapy Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Brachytherapy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Brachytherapy Market Size, by Equipment Type, 2025 vs 2032 (%)
FIGURE 13. Global Brachytherapy Market Size, by Equipment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Brachytherapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Brachytherapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Brachytherapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Brachytherapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Brachytherapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Brachytherapy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Brachytherapy Market Segmentation & Coverage
TABLE 2. Global Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 4. Global Interstitial Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Interstitial Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Interstitial Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intracavitary Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intracavitary Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intracavitary Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Surface Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Surface Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Surface Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 14. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Cancer Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cancer Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cancer Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Breast Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Breast Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Breast Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Hybrid Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Hybrid Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Hybrid Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global MammoSite Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global MammoSite Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global MammoSite Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global SAVIScout Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global SAVIScout Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global SAVIScout Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Gynecological Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Gynecological Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Gynecological Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Head And Neck Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Head And Neck Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Head And Neck Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Laryngeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Laryngeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Laryngeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Oropharyngeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Oropharyngeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Oropharyngeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Prostate Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Prostate Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Prostate Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 55. Global Afterloaders Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Afterloaders Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Afterloaders Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Applicators Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Applicators Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Applicators Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Imaging Systems Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Imaging Systems Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Imaging Systems Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Treatment Planning Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Treatment Planning Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Treatment Planning Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 75. North America Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. North America Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 77. North America Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. North America Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. North America Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 80. North America Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 81. North America Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 82. Latin America Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 84. Latin America Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. Latin America Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 87. Latin America Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 88. Latin America Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 89. Europe Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Europe Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 91. Europe Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Europe Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 94. Europe Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 95. Europe Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 96. Middle East Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Middle East Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 98. Middle East Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Middle East Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 101. Middle East Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 102. Middle East Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 103. Africa Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Africa Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 105. Africa Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Africa Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Africa Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 108. Africa Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 109. Africa Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 110. Global Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. ASEAN Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. ASEAN Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 116. ASEAN Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 117. ASEAN Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 118. GCC Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 120. GCC Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. GCC Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. GCC Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 123. GCC Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 124. GCC Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 125. European Union Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 127. European Union Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. European Union Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 130. European Union Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 131. European Union Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 132. BRICS Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. BRICS Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 134. BRICS Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. BRICS Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. BRICS Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 137. BRICS Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 138. BRICS Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 139. G7 Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. G7 Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 141. G7 Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. G7 Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 144. G7 Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 145. G7 Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 146. NATO Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. NATO Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 148. NATO Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. NATO Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 151. NATO Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 152. NATO Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 153. Global Brachytherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. United States Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 155. United States Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 156. United States Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. United States Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. United States Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 159. United States Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 160. United States Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 161. Canada Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 162. Canada Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 163. Canada Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Canada Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Canada Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 166. Canada Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 167. Canada Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 168. Mexico Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 169. Mexico Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 170. Mexico Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Mexico Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Mexico Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 173. Mexico Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 174. Mexico Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 175. Brazil Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 176. Brazil Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 177. Brazil Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Brazil Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Brazil Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 180. Brazil Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 181. Brazil Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 182. United Kingdom Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 183. United Kingdom Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 184. United Kingdom Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. United Kingdom Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. United Kingdom Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 187. United Kingdom Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 188. United Kingdom Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 189. Germany Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 190. Germany Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 191. Germany Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Germany Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Germany Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 194. Germany Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 195. Germany Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 196. France Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 197. France Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 198. France Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. France Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. France Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 201. France Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 202. France Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 203. Russia Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 204. Russia Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 205. Russia Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Russia Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. Russia Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 208. Russia Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 209. Russia Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 210. Italy Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 211. Italy Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 212. Italy Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Italy Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Italy Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 215. Italy Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 216. Italy Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 217. Spain Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 218. Spain Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 219. Spain Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Spain Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Spain Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 222. Spain Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 223. Spain Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 224. China Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 225. China Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 226. China Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. China Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. China Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 229. China Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 230. China Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 231. India Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 232. India Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 233. India Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. India Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. India Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 236. India Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 237. India Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 238. Japan Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 239. Japan Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 240. Japan Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Japan Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Japan Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 243. Japan Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 244. Japan Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 245. Australia Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 246. Australia Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 247. Australia Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Australia Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Australia Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 250. Australia Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 251. Australia Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 252. South Korea Brachytherapy Market Size, 2017-2032 (USD Million)
TABLE 253. South Korea Brachytherapy Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 254. South Korea Brachytherapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. South Korea Brachytherapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. South Korea Brachytherapy Market Size, by Breast, 2017-2032 (USD Million)
TABLE 257. South Korea Brachytherapy Market Size, by Head And Neck, 2017-2032 (USD Million)
TABLE 258. South Korea Brachytherapy Market Size, by Equipment Type, 2017-2032 (USD Million)
TABLE 259. Global Brachytherapy Market Share, by Key Player, 2025
TABLE 260. Global Brachytherapy Market, Key Experts

Companies Mentioned

  • Accuray Incorporated
  • BEBIG Medical GmbH
  • Becton, Dickinson and Company
  • Best Medical International, Inc.
  • BWX Technologies. Inc.
  • CivaTech Oncology Inc.
  • CIVCO Medical Solutions
  • CQ Medical
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GammaTile
  • Healvita Group GmbH
  • Hologic, Inc.
  • IsoAid, LLC
  • Mick Radio-Nuclear Instruments, Inc.
  • Mirion Technologies, Inc.
  • Perspective Therapeutics
  • Theragenics Corporation
  • Varian Medical Systems, Inc.

Related Topics

Related Reports

Brachytherapy Treatment Planning System Market - Global Forecast 2026-2032 - Product Image

Brachytherapy Treatment Planning System Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Brachytherapy Devices Market - Global Forecast 2026-2032 - Product Image

Brachytherapy Devices Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Brachytherapy - Global Strategic Business Report - Product Image

Brachytherapy - Global Strategic Business Report

  • Report
  • 261 Pages
  • Global
From
Brachytherapy Market Size, Share & Trends Analysis by Dosage Type, Application, Product Seeds, Applicators & Afterloaders, Electronic Brachytherapy, Region, and Segment Forecasts, 2026-2033 - Product Image

Brachytherapy Market Size, Share & Trends Analysis by Dosage Type, Application, Product Seeds, Applicators & Afterloaders, Electronic Brachytherapy, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Brachytherapy Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Brachytherapy Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 87 Pages
  • Global
From

About the Brachytherapy Market

Brachytherapy is a form of radiation therapy used in Nuclear Medicine and Radiopharmacology. It involves the placement of radioactive sources directly into or near a tumor, allowing for a higher dose of radiation to be delivered to the tumor while minimizing the dose to surrounding healthy tissue. Brachytherapy is used to treat a variety of cancers, including prostate, breast, and gynecological cancers. It is also used to treat benign conditions such as uterine fibroids. Brachytherapy is typically performed in an outpatient setting, and can be used as a primary treatment or in combination with other treatments such as surgery or external beam radiation therapy. The procedure is minimally invasive and can be completed in a single session. Some companies in the brachytherapy market include Elekta, Varian Medical Systems, C. R. Bard, and Nordion. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.